BORTEZ (BORTEZOMIB) is a proteasome inhibitor. It is indicated for multiple myeloma and mantle cell lymphoma.
| Product Name | Bortez |
| Generic Name | Bortezomib |
| Therapeutic Class | Proteasome inhibitor |
| Formulation | Lyophilized powder for injection |
| Available Pack Size | 1x1’s |
| Available Strength | 2 mg |